Callan JMB

Callan JMB Capital Intensity

The Capital Intensity Ratio of Callan JMB (CJMB) as of Oct 26, 2026 is 100.92 %. In the previous year, Capital Intensity Ratio was 77.44 % — a change of 30.32% (higher).

Capital Intensity

100.92 %

YoY

30.32%

Last updated:

Capital Intensity Ratio of Callan JMB is 2025 100.92 % . Capital Intensity Ratio of Callan JMB was 2024 77.44 % . It decreases by 30.32% higher compared to the previous year.

The Callan JMB Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2022
66.98 USD
Jan 1, 2023
73.51 USD
Jan 1, 2024
77.44 USD
Jan 1, 2025
100.92 USD
The Callan JMB Capital Intensity history
YEARCapital IntensityYoY
100.92 %+30.32%
77.44 %+5.34%
73.51 %+9.75%
66.98 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Callan JMB Stock analysis

What does Callan JMB do? Callan JMB Inc provides thermal management logistics solutions for the life sciences industry, including personalized medicine, cell therapies, and vaccines. The company's Ship2Q ultraviolet disinfection process ensures thermal reliability and cleanliness of packaging systems. Its vertically integrated model combines proprietary packaging, IT, and cold chain logistics expertise to serve clients requiring cryogenic or frozen shipping. The firm targets life sciences companies needing specialized shipping solutions for temperature-sensitive products. Callan JMB Inc's primary products include thermal management logistics services and the Ship2Q disinfection process. These solutions address the full range of frozen shipping needs in the life sciences sector. The company serves manufacturers of biopharmaceuticals, diagnostic materials, and other temperature-sensitive commodities. Its services ensure that shipping systems meet manufacturer specifications for fitness and thermal performance. The company's business model focuses on providing comprehensive alternatives to traditional logistics solutions for frozen shipping. It operates as a vertically integrated provider, handling all aspects of cold chain logistics from packaging to delivery. Callan JMB Inc's target clients are life sciences companies requiring reliable, temperature-controlled shipping for sensitive materials like cell lines, cord blood, and organs. The firm's proprietary technology differentiates it in the specialized logistics market. Callan JMB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Callan JMB stock

Capital Intensity Ratio of Callan JMB is 100.92 % in 2025.

Capital Intensity Ratio of Callan JMB changed from 77.44 % to 100.92 %, representing a 30.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Callan JMB since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Callan JMB with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Callan JMB

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Callan JMB